

Most Read This Week
- Active Surveillance of Metastatic Renal Cell Carcinoma
- Plasma KIM-1 Is Associated With Recurrence Risk After Nephrectomy for Localized Renal Cell Carcinoma
- First-Line Immunotherapy-Based Combinations for Metastatic Renal Cell Carcinoma
- Lenvatinib and Pembrolizumab Compared to Sunitinib for Advanced Renal Cell Carcinoma
- Characteristics and Survival Outcomes of Clear Cell Papillary RCC
Recently Updated
- Gastrointestinal Metastases From Primary RCC: A Single Center Review
- Reduced Renal Function Does Not Predispose to Cancer-Specific Mortality From RCC
- Lenvatinib With or Without Everolimus in Patients With Metastatic RCC After ICI and VEGFR-TKI Therapies
- Metastatic cRCC Post-Nephrectomy
- Single-Cell Analysis Reveals Metastatic Cell Heterogeneity in ccRCC